Background: Although promising for graft-versus-host disease (GvHD) treatment, MSC therapy still faces important challenges. For instance, increasing MSC migratory capacity as well as potentializing immune response suppression are of interest. For GvHD management, preventing opportunistic infections is also a valuable strategy, since immunocompromised patients are easy targets for infections. LL-37 is a host de...
Texto completo: acesso restrito. p. 850–855; Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-04-24T13:52:59Z No. of bitstreams: 1 Artur F. Barbosa.pdf: 86697 bytes, checksum: 4a92282542739db1e21fdff38552ed8d (MD5); Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-10-21T16:07:35Z (GMT) No. of bitstreams: 1 Artur F. Barbosa.pdf: 86697 bytes, checksum: 4a92282542739d...
p. 1-5; Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-08-19T11:59:03Z No. of bitstreams: 1 Bruno Sangiorgi.pdf: 1802159 bytes, checksum: 0577621a4189ecafeed156b99e638747 (MD5); Approved for entry into archive by Delba Rosa (delba@ufba.br) on 2014-10-09T15:38:34Z (GMT) No. of bitstreams: 1 Bruno Sangiorgi.pdf: 1802159 bytes, checksum: 0577621a4189ecafeed156b99e638747 (MD5); Made available in DSpac...